AMANDA WILDERMAN: Open Payments
NPI 1659915171 · COULTERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 37 payments from 11 companies in 2025. Trend: 2023 $755 · 2024 $1,337 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $205 |
| Phathom Pharmaceuticals, Inc. | 8 | $117 |
| GENZYME CORPORATION | 3 | $75 |
| Ardelyx, Inc. | 3 | $54 |
| Celltrion USA Inc. | 3 | $45 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Lilly USA, LLC | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: VOQUEZNA, RINVOQ, DUPIXENT, LINZESS, IBSRELA, VEGZELMA, ZENPEP, SKYRIZI.
Industry payments across IL — which companies pay providers there.
